A collection of information about biotech in Switzerland.
Wednesday, October 31, 2012
Covagen with Mitsubishi Tanabe Pharma Corporation
Covagen has just recently announced a partnership with Mitsubishi Tanabe Pharma Corporation to develop bispecific Fynomer binders against two target pairs selected by Mitsubishi Tanabe and will be paid EUR 4 million upfront.
No comments:
Post a Comment